These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2237821)

  • 1. Modifications of biological activities of heparin and fraxiparine induced by the size and the age of a thrombus. Experimental study.
    Doutremepuich C; Llido S; Lalanne MC; Doutremepuich F
    Thromb Res; 1990 Aug; 59(3):439-47. PubMed ID: 2237821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could thrombus age be a modulator of heparin or L.M.W.H. activities?
    Doutremepuich C; Lalanne MC; Doutremepuich F; Guyot M; De Sèze O
    Thromb Res; 1989 Aug; 55(4):407-17. PubMed ID: 2554523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the anticoagulant and anti-thrombotic effects of unfractionated heparin and a low molecular weight heparin (Fraxiparine) in an experimental model of human venous thrombosis.
    Diquélou A; Dupouy D; Cariou R; Sakariassen KS; Boneu B; Cadroy Y
    Thromb Haemost; 1995 Nov; 74(5):1286-92. PubMed ID: 8607111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant and antithrombotic properties of synthetic sulfated bis-lactobionic acid amides.
    Raake W; Klauser RJ; Elling H; Meinetsberger E
    Thromb Res; 1989 Dec; 56(6):719-30. PubMed ID: 2561233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor pathway inhibitor (TFPI) and its response to heparin in patients with spontaneous deep vein thrombosis.
    Holst J; Lindblad B; Wedeberg E; Bergqvist D; Nordfang O; Ostergaard PB; Hedner U
    Thromb Res; 1993 Dec; 72(5):467-70. PubMed ID: 8303690
    [No Abstract]   [Full Text] [Related]  

  • 6. Laboratory control of heparin and heparin fragment treatment: an experimental study.
    Doutremepuich C; Lalanne MC; Guyot M; Doutremepuich F; De Sèze O; Toulemonde F
    Semin Thromb Hemost; 1989 Oct; 15(4):373-7. PubMed ID: 2554497
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of antithrombotic activity of two heparin fragments PK 10169 (mol. wt. 5,000) and EMT 680 (mol. wt. 2,500) and unfractionated heparin in a rabbit experimental thrombosis model: relative importance of systemic anti-Xa and anti-IIa activities.
    Bara L; Trillou M; Mardiguian J; Samama M
    Nouv Rev Fr Hematol (1978); 1986; 28(6):355-8. PubMed ID: 3562219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dermatan sulfate and heparin on inhibition of thrombus growth in vivo.
    Van Ryn-McKenna J; Ofosu FA; Gray E; Hirsh J; Buchanan MR
    Ann N Y Acad Sci; 1989; 556():304-12. PubMed ID: 2735661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does glycosylation influence the experimental antithrombotic effect of a two-domain tissue factor pathway inhibitor?
    Holst J; Lindblad B; Nordfang O; Ostergaard PB; Hedner U
    Haemostasis; 1996; 26(1):23-30. PubMed ID: 8698275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of sodium pentosanpolysulfate and unfractionated heparin on venous thrombosis; an experimental study in rats.
    Kiesel J; Harbauer G; Wenzel E; Pindur G; Bohnerth S
    Thromb Res; 1991 Nov; 64(3):301-8. PubMed ID: 1725226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study on the effects of a low molecular weight heparin (CY 216) and standard heparin in low dosage on experimental venous thrombosis.
    Doutremepuich C; Bousquet F; Gestreau GL; Toulemonde F; Bayrou B
    Haemostasis; 1987; 17(4):201-5. PubMed ID: 3623263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic potencies of heparins in relation to their antifactor Xa and antithrombin activities: an experimental study in two models of thrombosis in the rabbit.
    Amar J; Caranobe C; Sie P; Boneu B
    Br J Haematol; 1990 Sep; 76(1):94-100. PubMed ID: 2223652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of immuno-potent drugs and their association with an unfractionated heparin on an experimental venous thrombosis.
    Puyal C; Lalanne MC; Doutremepuich C
    Thromb Res; 1991 Oct; 64(2):263-72. PubMed ID: 1811344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of heparin and a low molecular weight heparin fraction of the leukocytes in an experimental venous thrombosis model.
    Doutremepuich C; Toulemonde F; de Seze O; Pereira F; Anne MC; Doutremepuich F
    J Leukoc Biol; 1987 Dec; 42(6):628-31. PubMed ID: 2824648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time.
    Sato K; Kawasaki T; Hisamichi N; Taniuchi Y; Hirayama F; Koshio H; Matsumoto Y
    Br J Pharmacol; 1998 Jan; 123(1):92-6. PubMed ID: 9484858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the antithrombotic effects of heparin and of low molecular weight heparins with increasing antifactor Xa/antifactor IIa ratio in the rabbit.
    Carrie D; Caranobe C; Boneu B
    Br J Haematol; 1993 Apr; 83(4):622-6. PubMed ID: 8390849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis.
    Heran C; Morgan S; Kasiewski C; Bostwick J; Bentley R; Klein S; Chu V; Brown K; Colussi D; Czekaj M; Perrone M; Leadley R
    Eur J Pharmacol; 2000 Feb; 389(2-3):201-7. PubMed ID: 10688985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative efficacy of heparin and related glycosaminoglycans as antithrombotic drugs.
    Thomas DP; Merton RE; Barrowcliffe TW
    Ann N Y Acad Sci; 1989; 556():313-22. PubMed ID: 2735662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative.
    Kaiser B; Hauptmann J; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):119-25. PubMed ID: 2459005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant activity in the plasma after a single administration of nebulized heparin or LMW heparin fraction (Fraxiparine) in patients undergoing abdominal surgery.
    Lewandowski K; Psuja P; Tokarz A; Zozulínska M; Sowier J; Zawilska K
    Thromb Res; 1990 Jun; 58(5):525-30. PubMed ID: 2368037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.